← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 1, 2016Last known activity
Aug 1, 2022
Acquired by Bayer on Aug 11, 2020
Timeline
2010s
- Jun 1, 2012
NeRRe Therapeutics Ltd.— Founded
2020s
- Aug 11, 2020
Bayer— Acquired By
Drugs by trial phase (3 distinct, 8 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (9)
- NCT05185089Lead sponsorPhase 2Aug 1, 2022
- NCT04654897Lead sponsorPhase 1Sep 30, 2020
- NCT04387981Lead sponsorPhase 1May 21, 2020
- NCT03596762Lead sponsorPhase 2Oct 31, 2018
- NCT03535662Lead sponsorPhase 1Jun 8, 2018
- NCT03464526Lead sponsorPhase 2May 31, 2018
- NCT02993822Lead sponsorPhase 2May 10, 2017
- NCT02865538Study directorPhase 1/Phase 2Aug 1, 2016
- NCT02865538Lead sponsorPhase 1/Phase 2Aug 1, 2016
Details
- Founded
- Stevenage, GB Jun 1, 2012
- Last known activity
- Aug 1, 2022